American International Group, Inc. Akebia Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.67 $27,709 - $58,017	-86,593 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.72 - $2.93 $4,388 - $17,858	-6,095 Reduced 6.58%	86,593 $62,000
Q4 2021 Feb 11, 2022	SELL	$2.26 - $3.34 $6,266 - $9,261	-2,773 Reduced 2.9%	92,688 $209,000
Q3 2021 Nov 12, 2021	BUY	$2.35 - $3.88 $13,919 - $22,981	5,923 Added 6.62%	95,461 $275,000
Q2 2021 Aug 13, 2021	BUY	$2.83 - $4.2 $17,166 - $25,477	6,066 Added 7.27%	89,538 $339,000
Q1 2021 May 07, 2021	BUY	$2.92 - $5.06 $642 - $1,113	220 Added 0.26%	83,472 $283,000
Q4 2020 Feb 12, 2021	SELL	$2.22 - $3.78 $5,301 - $9,026	-2,388 Reduced 2.79%	83,252 $233,000
Q3 2020 Nov 04, 2020	BUY	$2.39 - $13.08 $14,409 - $78,859	6,029 Added 7.57%	85,640 $215,000
Q2 2020 Aug 12, 2020	BUY	$6.67 - $13.58 $64,859 - $132,051	9,724 Added 13.91%	79,611 $1.08 Million
Q1 2020 May 04, 2020	SELL	$4.1 - $10.24 $16,559 - $41,359	-4,039 Reduced 5.46%	69,887 $530,000
Q4 2019 Feb 05, 2020	SELL	$3.16 - $6.73 $1,965 - $4,186	-622 Reduced 0.83%	73,926 $467,000
Q3 2019 Nov 08, 2019	SELL	$3.55 - $5.4 $1,846 - $2,808	-520 Reduced 0.69%	74,548 $292,000
Q2 2019 Aug 13, 2019	BUY	$4.1 - $8.05 $83,451 - $163,849	20,354 Added 37.2%	75,068 $363,000
Q1 2019 May 06, 2019	SELL	$5.41 - $8.73 $9,586 - $15,469	-1,772 Reduced 3.14%	54,714 $448,000
Q4 2018 Feb 13, 2019	BUY	$5.39 - $9.15 $124,174 - $210,797	23,038 Added 68.88%	56,486 $312,000
Q3 2018 Nov 09, 2018	BUY	$7.44 - $10.65 $4,478 - $6,411	602 Added 1.83%	33,448 $295,000
Q2 2018 Aug 08, 2018	BUY	$9.15 - $11.34 $38,731 - $48,002	4,233 Added 14.79%	32,846 $328,000
Q1 2018 May 07, 2018	SELL	$9.53 - $15.68 $14,657 - $24,115	-1,538 Reduced 5.1%	28,613 $273,000
Q4 2017 Feb 09, 2018	BUY	$14.24 - $19.59 $6,137 - $8,443	431 Added 1.45%	30,151 $448,000
Q3 2017 Nov 09, 2017	BUY	$13.06 - $19.67 $388,143 - $584,592	29,720	29,720 $585,000

Others Institutions Holding AKBA

# of Institutions

110

Shares Held

55.3M

Call Options Held

554K

Put Options Held

246K

Black Rock Inc. New York, NY

11.6M
Shares

$15.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

9.28M
Shares

$12.3 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$7.64 Million
11.5% of portfolio
Geode Capital Management, LLC Boston, MA

4.54M
Shares

$6.03 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

4.06M
Shares

$5.4 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $245M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account